What to Watch When Johnson & Johnson Reports Tomorrow
Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday.
All Work
Chris Lange
What to Expect When Goldman Sachs, JPMorgan and Wells Fargo Report Tuesday
Practically all the major banks are coming out with their earnings this week. We have already seen Citigroup report with a decent bottom-line beat. In fact a few of these banks are coming out…
Why Capricor May Be the Next Big Name in Duchenne Muscular Dystrophy
Capricor Therapeutics shares more than doubled on Monday after the firm announced interim analysis for its Duchenne muscular dystrophy midstage trial.
Is It a Good Idea for Circor to Reject Crane’s Bid?
Circor shares were crushed on Monday after it came out that the firm’s board of directors had unanimously rejected a buyout bid. Specifically, this was a revised acquisition bid from Crane.
Alkermes Looks to Expand Its Schizophrenia Treatment to Bipolar Patients
Alkermes shares made a handy gain on Monday after the firm announced that it would be expanding its New Drug Application for ALKS 3831 to encompass the treatment of bipolar I disorder in addition…
Does Citigroup Deserve More Credit for This Bottom-Line Beat?
Citigroup released its second quarter financial results before the markets opened on Monday. The bank said that it had $1.95 in earnings per share (EPS) and $18.76 billion in revenue, compared with consensus estimates…
JPMorgan, Wells Fargo, Citigroup, Goldman Sachs and More Major Financial Earnings This Week
24/7 Wall St. has put together a preview of some of the major financial companies kicking off the new earnings reporting season. Markets have been pushed to record highs, and these major banks reporting…
Microsoft, Netflix, eBay, Johnson & Johnson and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of Johnson & Johnson, Microsoft, Netflix and the other most prominent of the many earnings reports that are expected this week.
Short Sellers Run for Cover From Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most of these…
Why Canaccord Genuity Is on the Sideline About Illumina
Illumina shares dropped on Friday after the firm announced a preliminary revenue miss and a 50% cut to its 2019 revenue growth guidance. As a result, a few analysts were quick to weigh in…
What’s So Great About Hookipa Pharma’s HPV Cancer Treatment
Hookipa Pharma is not a household name, or even well-known within the biotech industry, but it is making waves on Friday after the firm announced an update from the FDA.
As the Summer Heats Up, the Economy Cools Down
There is something to the market adage “Sell in May and go away,” and it’s not just that traders and people in general are taking vacations over the summer and business tends to slow…
Why This Analyst Sees Snap on the Rise
Snap shares saw a handy gain on Thursday after a couple of analysts were calling for more upside for the stock. A recent spike in downloads suggests this uptick, and Merrill Lynch is responding…
Short Sellers Get Even Higher on Cannabis Stocks
The June 28 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Short Sellers Run for Cover From Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most of these…
Big Pharma Sees Rising Tide in Short Interest
The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were increased.
Is Semiconductor Short Interest Signaling Higher Highs?
The June 28 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks increased.
What to Expect When Delta Air Lines Reports Thursday
Delta Air Lines is scheduled to release its second quarter financial results before the markets open on Thursday. The consensus estimates are calling for $2.25 in earnings per share (EPS) and $12.48 billion in…
Will Sangamo and Pfizer’s Hemophilia Gene Therapy Keep Building Momentum?
Sangamo Therapeutics made a handy gain to start out the week after the firm, in conjunction with Pfizer, announced updated results from a mid-stage trial evaluating a treatment for hemophilia.
What Analysts Are Saying About PepsiCo After Earnings
When PepsiCo released its second-quarter financial results before the markets opened on Tuesday, investors were not particularly impressed with the results. Analysts seemed to hold a similar sentiment.